Biosensor diagnosis of urinary tract infections: A path to better treatment?

Trends in Pharmacological Sciences

Volumn 32, Issue 6, 2011, Pages 330-336

  Mach, Kathleen E ^a,b   Wong, Pak Kin ^c   Liao, Joseph C ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c University of Arizona   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL RNA; COTRIMOXAZOLE; GLUCOSE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RNA 16S;

ANTIBIOTIC SENSITIVITY; AUTOANALYSIS; BACTERIUM DETECTION; BIOSENSOR; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ELECTROCHEMICAL ANALYSIS; HUMAN; INTERMETHOD COMPARISON; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROFLUIDIC ANALYSIS; NANOTECHNOLOGY; NONHUMAN; NOTE; POINT OF CARE TESTING; PORTABLE EQUIPMENT; PREGNANCY TEST; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; URINARY TRACT INFECTION; URINE CULTURE; UROLOGIC EXAMINATION;

EID: 79957734293     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2011.03.001     Document Type: Review

References (79)

1. Foxman, B. (2010) The epidemiology of urinary tract infection. Nat. Rev. Urol. 7, 653-660
2. Dielubanza, E.J. and Schaeffer, A.J. (2011) Urinary tract infections in women. Med. Clin. N. Am. 95, 27-41
3. Foxman, B. (2002) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am. J. Med. 113 (Suppl. 1A), 5S-13S
4. Griebling, T.L. (2005) Urologic diseases in america project: trends in resource use for urinary tract infections in men. J. Urol. 173, 1288-1294
5. Griebling, T.L. (2005) Urologic diseases in America project: trends in resource use for urinary tract infections in women. J. Urol. 173, 1281-1287
6. Raynor, M.C. and Carson, C.C., 3rd (2011) Urinary infections in men. Med. Clin. N. Am. 95, 43-54
7. Klevens, R.M. et al. (2007) Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 122, 160-166
8. Nicolle, L. (2001) Epidemiology of urinary tract infection. Infect. Med. 18, 153-162
9. Schappert, S.M. and Burt, C.W. (2006) Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-02. Vital Health Stat. 13, 1-66
10. Kunin, C. (1997) Diagnostic methods, In Urinary Tract Infections: Detection, Prevention, and Management, Williams &Wilkins, pp. 42-77
11. Boucher, H.W. (2010) Challenges in anti-infective development in the era of bad bugs, no drugs: a regulatory perspective using the example of bloodstream infection as an indication. Clin. Infect. Dis. 50 (Suppl. 1), S4-S9
12. Zhanel, G.G. et al. (2006) Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int. J. Antimicrob. Agents 27, 468-475
13. Ho, P.L. et al. (2007) Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypes. Diagn. Microbiol. Infect. Dis. 59, 439-445
14. Johnson, L. et al. (2008) Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am. J. Med. 121, 876-884
15. Boyd, L.B. et al. (2008) Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location. BMC Infect. Dis. 8, 4
16. Jensen, U.S. et al. (2010) Effect of generics on price and consumption of ciprofloxacin in primary healthcare: the relationship to increasing resistance. J. Antimicrob. Chemother. 65, 1286-1291
17. Freeman, J.T. et al. (2009) Emergence of extended-spectrum beta-lactamase-producing Escherichia coli in community hospitals throughout North Carolina: a harbinger of a wider problem in the United States? Clin. Infect. Dis. 49, e30-32
18. Routh, J.C. et al. (2009) Increasing prevalence and associated risk factors for methicillin-resistant Staphylococcus aureus bacteriuria. J. Urol. 181, 1694-1698
19. Deville, W.L. et al. (2004) The urine dipstick test useful to rule out infections A meta-analysis of the accuracy. BMC Urol. 4, 4
20. Jolkkonen, S. et al. (2010) Screening of urine samples by flow cytometry reduces the need for culture. J. Clin. Microbiol. 48, 3117-3121
21. Pieretti, B. et al. (2010) Diagnosis of bacteriuria and leukocyturia by automated flow cytometry compared with urine culture. J. Clin. Microbiol. 48, 3990-3996
22. Schwartz, D.S. and Barone, J.E. (2006) Correlation of urinalysis and dipstick results with catheter-associated urinary tract infections in surgical ICU patients. Intensive Care Med. 32, 1797-1801 (Pubitemid 44607368)
23. Eigner, U. et al. (2005) Analysis of the comparative workflow and performance characteristics of the VITEK 2 and Phoenix systems. J. Clin. Microbiol. 43, 3829-3834
24. Thomson, K.S. et al. (2007) Comparison of Phoenix and VITEK 2 extended-spectrum-beta-lactamase detection tests for analysis of Escherichia coli and Klebsiella isolates with well-characterized beta-lactamases. J. Clin. Microbiol. 45, 2380-2384
25. Drummond, T.G. et al. (2003) Electrochemical DNA sensors. Nat. Biotechnol. 21, 1192-1199
26. Hunt, H.K. and Armani, A.M. (2010) Label-free biological and chemical sensors. Nanoscale 2, 1544-1559
27. Lee, T.M. (2008) Over-the-counter biosensors: past, present, and future. Sensors 8, 5535-5559
28. Llandro, J. et al. (2010) Magnetic biosensor technologies for medical applications: a review. Med. Biol. Eng. Comput. 48, 977-998
29. Newman, J.D. and Setford, S.J. (2006) Enzymatic biosensors. Mol. Biotechnol. 32, 249-268
30. Oh, K.J. et al. (2009) Beyond molecular beacons: optical sensors based on the binding-induced folding of proteins and polypeptides. Chemistry 15, 2244-2251
31. Rapp, B.E. et al. (2010) Biosensors with label-free detection designed for diagnostic applications. Anal. Bioanal. Chem. 398, 2403-2412
32. Ronkainen, N.J. et al. (2010) Electrochemical biosensors. Chem. Soc. Rev. 39, 1747-1763
33. Wang, J. (2006) Electrochemical biosensors: towards point-of-care cancer diagnostics. Biosens. Bioelectron. 21, 1887-1892
34. Eichner, S.F. and Timpe, E.M. (2004) Urinary-based ovulation and pregnancy: point-of-care testing. Ann. Pharmacother. 38, 325-331
35. Rider, T.H. et al. (2003) A B-cell-based sensor for rapid identification of pathogens. Science 301, 213-215 (Pubitemid 36858474)
36. Tsutsui, M. et al. (2011) Single-molecule identification via electric current noise. Nat. Commun. 1, 138
37. Oliver, N.S. et al. (2009) Glucose sensors: a review of current and emerging technology. Diabet. Med. 26, 197-210
38. Chard, T. (1992) Pregnancy tests: a review. Hum. Reprod. 7, 701-710
39. Erickson, K.A. and Wilding, P. (1993) Evaluation of a novel point-of-care system, the i-STAT portable clinical analyzer. Clin. Chem. 39, 283-287
40. Kissinger, P.T. (2005) Biosensors - a perspective. Biosens. Bioelectron. 20, 2512-2516
41. Newman, J.D. and Turner, A.P. (2005) Home blood glucose biosensors: a commercial perspective. Biosens. Bioelectron. 20, 2435-2453
42. Liu, R.H. et al. (2004) Self-contained, fully integrated biochip for sample preparation, polymerase chain reaction amplification, and DNA microarray detection. Anal. Chem. 76, 1824-1831
43. Chutipongtanate, S. and Thongboonkerd, V. (2010) Systematic comparisons of artificial urine formulas for in vitro cellular study. Anal. Biochem. 402, 110-112
44. Echeverry, G. et al. (2010) Introduction to urinalysis: historical perspectives and clinical application. Methods Mol. Biol. 641, 1-12
45. Liao, J.C. et al. (2006) Use of electrochemical DNA biosensors for rapid molecular identification of uropathogens in clinical urine specimens. J. Clin. Microbiol. 44, 561-570
46. Liao, J.C. et al. (2007) Development of an advanced electrochemical DNA biosensor for bacterial pathogen detection. J. Mol. Diagn. 9, 158-168
47. Mach, K.E. et al. (2009) Multiplex pathogen identification for polymicrobial urinary tract infections using biosensor technology: a prospective clinical study. J. Urol. 182, 2735-2741
48. Mach, K.E. et al. (2011) A biosensor platform for rapid antimicrobial susceptibility testing driectly from clinical samples. J. Urol. 185, 148-153
49. Chaki, N.K. and Vijayamohanan, K. (2002) Self-assembled monolayers as a tunable platform for biosensor applications. Biosens. Bioelectron. 17, 1-12
50. Pan, Y. et al. (2010) Electrochemical immunosensor detection of urinary lactoferrin in clinical samples for urinary tract infection diagnosis. Biosens. Bioelectron. 26, 649-654
51. DeLong, E.F. et al. (1989) Phylogenetic stains: ribosomal RNA-based probes for the identification of single cells. Science 243, 1360-1363 (Pubitemid 19085373)
52. Woo, P.C. et al. (2008) Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories. Clin. Microbiol. Infect. 14, 908-934
53. Gau, V. et al. (2005) Electrochemical molecular analysis without nucleic acid amplification. Methods 37, 73-83 (Pubitemid 41443377)
54. Boehme, C.C. et al. (2010) Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 363, 1005-1015
55. Lehmann, L.E. et al. (2009) Real-time polymerase chain-reaction detection of pathogens is feasible to supplement the diagnostic sequence for urinary tract infections. BJU Int. 106, 114-120
56. Lehmann, L.E. et al. (2011) Rapid qualitative urinary tract infection pathogen identification by Septifast real-time PCR. PLoS ONE 6, e17146
57. Holland, R.D. et al. (1996) Rapid identification of intact whole bacteria based on spectral patterns using matrix-assisted laser desorption/ionization with time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 10, 1227-1232
58. Holland, T.L. et al. (2009) Antibacterial susceptibility testing in the clinical laboratory. Infect. Dis. Clin. N. Am. 23, 757-790 vii
59. Ferreira, L. et al. (2010) Rapidmethod for direct identification of bacteria in urine and blood culture samples by matrix-assisted laser desorption ionization time-of-flight mass spectrometry: intact cell vs. extraction method. Clin.Microbiol. Infect. DOI: 10.1111/j.1469-0691.2010.03339.x
60. Carbonnelle, E. et al. (2011) MALDI-TOF mass spectrometry tools for bacterial identification in clinical microbiology laboratory. Clin. Biochem. 44, 104-109
61. Fenselau, C. and Demirev, P.A. (2001) Characterization of intact microorganisms by MALDI mass spectrometry. Mass Spectrom. Rev. 20, 157-171
62. Tenover, F.C. (2010) Potential impact of rapid diagnostic tests on improving antimicrobial use. Ann. N. Y. Acad. Sci. 1213, 70-80
63. Parta, M. et al. (2009) Identification of methicillin-resistant or methicillin-susceptible Staphylococcus aureus in blood cultures and wound swabs by GeneXpert. J. Clin. Microbiol. 47, 1609-1610
64. Stamper, P.D. et al. (2007) Clinical validation of the molecular BD GeneOhm StaphSR assay for direct detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in positive blood cultures. J. Clin. Microbiol. 45, 2191-2196
65. U.S. Department of Health and Human Services, Center for Devices and Radiological Health (2009) Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test (AST) Systems, Document 631, Food and Drug Administration
66. Lawi, W. et al. (2009) A microfluidic cartridge system for multiplexed clinical analysis. JALA Charlottesv Va 14, 407-412
67. Mariella, R., Jr (2008) Sample preparation: the weak link in microfluidics-based biodetection. Biomed. Microdev. 10, 777-784
68. Schulze, H. et al. (2009) Multiplexed optical pathogen detection with lab-on-a-chip devices. J. Biophotonics 2, 199-211
69. Feldman, H.C. et al. (2007) AC electrothermal enhancement of hetergeneous assays in microfluidics. Lab Chip 7, 1553-1559 (Pubitemid 350013183)
70. Liu, J. et al. (2003) Solving the 'world-to-chip' interface problem with a microfluidic matrix. Anal. Chem. 75, 4718-4723
71. Melin, J. and Quake, S.R. (2007) Microfluidic large-scale integration: the evolution of design rules for biological automation. Annu. Rev. Biophys. Biomol. Struct. 36, 213-231
72. Stone, H.A. et al. (2004) Engineering flows in small devices: Microfluidics toward a lab-on-a-chip. Annu. Rev. Fluid Mechanics 36, 381-411
73. Sin, M.L. et al. (2010) Electrothermal fluid manipulation of high-conductivity samples for laboratory automation applications. JALA Charlottesv Va 15, 426-432
74. Sin, M.L.Y. et al. (2009) Active manipulation of quantum dots using AC electrokinetics. J. Phys. Chem. 113, 6561-6565
75. Imirzalioglu, C. et al. (2008) Hidden pathogens uncovered: metagenomic analysis of urinary tract infections. Andrologia 40, 66-71 (Pubitemid 351379675)
76. Sturm, P.D. et al. (2006) Urosepsis with Actinobaculum schaalii and Aerococcus urinae. J. Clin. Microbiol. 44, 652-654
77. Nanda, N. and Juthani-Mehta, M. (2009) Novel biomarkers for the diagnosis of urinary tract infection-a systematic review. Biomark Insights 4, 111-121
78. (1980). Home blood-glucose monitoring: revolution, revelation, or ripoff? Lancet 2, 187-188.
79. Harrad, R.H. et al. (1983) Intensive attention improves glycaemic control in insulin dependent diabetes without further advantage from home blood glucose monitoring. Br. Med. J. (Clin. Res. Ed.) 286, 59